Cerebral and Tissue Oximetry Device Market Size

  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Cerebral and Tissue Oximetry Device Market Size

Cerebral and Tissue Oximetry Device Market size was valued at USD 237.06 million in 2024 and is set to cross USD 531.01 million by the end of 2037, expanding at more than 6.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cerebral and tissue oximetry device is estimated at USD 249.2 million. A significant market driver is the increasing number of surgical procedures performed in traditional operating rooms and outpatient settings. In view of the increasing number of complex procedures, cerebral and tissue oximetry device play an important role in the monitoring of tissue oxygen levels during surgery, enabling surgeons to make informed decisions and potentially reduce complications. In comparison with the global estimate of 5000 surgeries for every 100,000 people, a total of 3646 procedures are expected each year to meet the needs of India's population.

The demand for cerebral and tissues oximetry devices is driven by a growing preference to non-invasive medical surveillance. These technologies are used by both patients and healthcare professionals, because they allow the provision of Realtime data that does not involve inoperative procedures, improve patient comfort and reduce potential risks resulting from traditional methods.


Cerebral-and-Tissue-Oximetry-Device-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cerebral and tissue oximetry device is estimated at USD 249.2 million.

Cerebral and Tissue Oximetry Device Market size was valued at USD 237.06 million in 2024 and is set to cross USD 531.01 million by the end of 2037, expanding at more than 6.4% CAGR during the forecast period i.e., between 2025-2037. The growing technological advancement and increasing collaboration for research and development will drive the market growth.

North America industry is anticipated to hold largest revenue share of 35% by 2037, due to rising substantial prevalence of cardiovascular disease in the region.

The major players in the market are of Brain Scientific Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nihon Kohden Corporation, Sotera Health Co., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample